Across early-phase and retrospective studies, responses to checkpoint-based combinations have been observed more often in patients without active liver metastases in microsatellite-stable colorectal cancer. (Frontiers in Immunology)
Liver metastases amplify immune resistance in MSS colorectal cancer
The CRC Digest